Evaluation of the Durability of the Immune Humoral Response to COVID-19 Vaccines in Patients With Cancer Undergoing Treatment or Who Received a Stem Cell Transplant.

Saved in:
Bibliographic Details
Title: Evaluation of the Durability of the Immune Humoral Response to COVID-19 Vaccines in Patients With Cancer Undergoing Treatment or Who Received a Stem Cell Transplant.
Authors: Khan QJ; Department of Internal Medicine, The University of Kansas Medical Center, Kansas City., Bivona CR; Department of Pharmacy, The University of Kansas Health System, Kansas City., Martin GA; Department of Pharmacy, The University of Kansas Health System, Kansas City., Zhang J; Department of Internal Medicine, The University of Kansas Medical Center, Kansas City.; Department of Cancer Biology, The University of Kansas Medical Center, Kansas City., Liu B; Department of Electrical Engineering and Computer Science, The University of Kansas, Lawrence., He J; Department of Biostatistics and Data Science, The University of Kansas Medical Center, Kansas City., Li KH; School of Medicine, The University of Kansas Medical Center, Kansas City., Nelson M; Department of Pharmacy, The University of Kansas Health System, Kansas City., Williamson S; Department of Internal Medicine, The University of Kansas Medical Center, Kansas City., Doolittle GC; Department of Internal Medicine, The University of Kansas Medical Center, Kansas City., Sun W; Department of Internal Medicine, The University of Kansas Medical Center, Kansas City., Mudaranthakam DP; Department of Biostatistics and Data Science, The University of Kansas Medical Center, Kansas City., Streeter NR; Clinical Research, Strategy & Operations, The University of Kansas Medical Center, Kansas City., McGuirk JP; Department of Internal Medicine, The University of Kansas Medical Center, Kansas City., Al-Rajabi R; Department of Internal Medicine, The University of Kansas Medical Center, Kansas City., Hoffmann M; Department of Internal Medicine, The University of Kansas Medical Center, Kansas City., Kasi A; Department of Internal Medicine, The University of Kansas Medical Center, Kansas City., Parikh RA; Department of Internal Medicine, The University of Kansas Medical Center, Kansas City., Zhong C; Department of Electrical Engineering and Computer Science, The University of Kansas, Lawrence., Mitchell L; Clinical Research, Strategy & Operations, The University of Kansas Medical Center, Kansas City., Pessetto ZY; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City., Pathak H; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City., Ghosh A; Department of Zoology, Rajiv Gandhi University, Arunachal Pradesh, India., LaFaver S; Department of Nursing, The University of Kansas Medical Center, Kansas City., Sharma P; Department of Internal Medicine, The University of Kansas Medical Center, Kansas City., Godwin AK; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City.; The University of Kansas Cancer Center, Kansas City.
Source: JAMA oncology [JAMA Oncol] 2022 Jul 01; Vol. 8 (7), pp. 1053-1058.
Publication Type: Journal Article; Observational Study; Research Support, N.I.H., Extramural
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2374-2445
DOI:10.1001/jamaoncol.2022.0752